Phase II study of a weekly liposomal paclitaxel formulation (Genexol®-PM) and gemcitabine® combination chemotherapy in patients with advanced biliary cancer.

被引：0
|
作者：
Uk, Keon Kean Uk [1 ]
Kim, Jin Young [1 ]
Do, Young Rok [1 ]
Song, Hong Suk [1 ]
Jeon, Young June [1 ]
Ryoo, Hun Mo [2 ]
Bae, Sung Hwa [2 ]
Kim, Jong Gwang [3 ]
Baek, Jin Ho [4 ]
Chae, Yee Soo [3 ]
Kim, Min Kyoung [5 ]
Lee, Kyung Hee [5 ]
Cho, Yoon Young [6 ]
机构：
[1] Keimyung Univ, Dongsan Med Ctr, Taegu, South Korea
[2] Daegu Catholic Univ Hosp, Taegu, South Korea
[3] Kyungpook Natl Univ Hosp, Taegu, South Korea
[4] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan 680749, South Korea
[5] Yeungnam Univ Hosp, Taegu, South Korea
[6] Dongguk Univ, Med Ctr, Gyeongju, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4659
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase Ib study of gemcitabine and oxaliplatin with erlotinib in patients with advanced biliary tract cancer.
    Ciombor, Kristen Keon
    Cardin, Dana Backlund
    Chan, Emily
    McClanahan, Pamela
    Fan, Kang-Hsien
    Flynn, Jayme
    Young, Ruth T.
    DeMers, April
    Smith, Stephen James
    Berlin, Jordan
    Goff, Laura Williams
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial
    Loehr, J. M.
    Haas, S. L.
    Bechstein, W. -O.
    Bodoky, G.
    Cwiertka, K.
    Fischbach, W.
    Foelsch, U. R.
    Jaeger, D.
    Osinsky, D.
    Prausova, J.
    Schmidt, W. E.
    Lutz, M. P.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1214 - 1222
  • [43] CATIONIC LIPOSOMAL PACLITAXEL IN COMBINATION WITH GEMCITABINE IN PATIENTS WITH UNRESECTABLE PANCREATIC CANCER: A RANDOMIZED CONTROLLED PHASE II TRIAL
    Lohr, M.
    Graeven, U.
    Bodoky, G.
    Maerten, A.
    Lilla, C.
    Meyer, I
    Osinsky, D.
    Cwiertka, K.
    Foelsch, U.
    Lutz, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 9 - 9
  • [44] Phase II Study of Weekly Paclitaxel and Cisplatin Combination Therapy for Advanced or Recurrent Gastric Cancer
    Nagata, Naoki
    Kimura, Masayuki
    Hirabayashi, Naoki
    Tuburaya, Ahira
    Murata, Teruo
    Kondo, Ken
    Fukuda, Yasuhiko
    Kobayashi, Michiya
    Miyashita, Yumi
    Nakao, Akimasa
    Sahamoto, Junichi
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1846 - 1850
  • [45] PHASE II STUDY OF GEMCITABINE/S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Kanai, Masashi
    Hatano, Etsuro
    Tsumura, Takehiko
    Asada, Masanori
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Hamada, Akihiko
    Inoue, Naoya
    Mori, Yukiko
    Yoshimura, Kenichi
    Tada, Shinsuke
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Osaki, Yukio
    Chiba, Tsutomu
    ANNALS OF ONCOLOGY, 2010, 21 : 19 - 19
  • [46] Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small-cell lung cancer(NSCLC)
    Kisohara, Akira
    Takahashi, Noriaki
    Tsujino, Ichirou
    Sato, Maki
    Horie, Takashi
    ANNALS OF ONCOLOGY, 2004, 15 : 180 - 180
  • [47] Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study
    Nam, So Hyun
    Lee, Shin-Wha
    Lee, Young-Jae
    Kim, Yong Man
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1346 - 1354
  • [48] Phase II study of pazopanib with weekly paclitaxel in refractory urothelial cancer.
    Srinivas, Sandy
    Narayanan, Sujata
    Harshman, Lauren Christine
    Pachynski, Russell Kent
    Lam, Anthony P.
    Fan, Alice C.
    Poushnejad, Shermeen
    Haas, Denise
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [49] Preliminary assessment of a phase II study of paclitaxel and gemcitabine in combination in patients with advanced NSCLC.
    Isla, MD
    Martin, C
    González, LJL
    Felip, E
    Camps, C
    Carrato, A
    Antón, A
    Alberola, V
    Azagra, P
    Massutti, B
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S69 - S69
  • [50] Alternating weekly administration of paclitaxel and gemcitabine: a phase II study in patients with advanced non-small-cell lung cancer
    David Aguiar
    José Aguiar
    Uriel Bohn
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 152 - 158
12345